Literature DB >> 7506664

Inhibition of nitric oxide formation by guanidines.

K Hasan1, B J Heesen, J A Corbett, M L McDaniel, K Chang, W Allison, B H Wolffenbuttel, J R Williamson, R G Tilton.   

Abstract

Aminoguanidine, N,N'-diaminoguanidine, methylguanidine, and 1,1-dimethylguanidine were compared to NG-monomethyl-L-arginine (L-NMMA) for their ability to inhibit nitric oxide (NO) formation by cytokine-inducible and vascular constitutive isoforms of NO synthase. These comparisons were performed by assessing (1) cytokine-induced production of nitrite by RINm5F cells, (2) vasoconstrictor responses of isolated rat mesenteric arteries, and (3) in vivo blood pressure responses following intravenous bolus injection into anesthetized rats. Aminoguanidine and L-NMMA were the most potent inhibitors of cytokine-induced NO formation in RINm5F cells, while the other guanidine compounds were 10 (1,1-dimethylguanidine) to 100 (methylguanidine) times less potent. L-NMMA and 1,1-dimethylguanidine were the most potent inhibitors of the vascular constitutive isoform of NO synthase in both assay systems, while aminoguanidine and N,N'-diaminoguanidine were the least potent. These results (1) confirm the selective inhibition of the inducible isoform of NO synthase by aminoguanidine, (2) indicate that N,N'-diaminoguanidine, while approximately 30 times less potent than aminoguanidine in inhibiting inducible NO synthase, has very little effect on constitutive NO synthase activity, and (3) 1,1-dimethylguanidine, like L-NMMA, is a relatively potent inhibitor of both isoforms of NO synthase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506664     DOI: 10.1016/0014-2999(93)90667-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  29 in total

Review 1.  Alternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic Inflammation.

Authors:  Mohamed F El-Refaei; Suha H Abduljawad; Ahmed H Alghamdi
Journal:  Rev Diabet Stud       Date:  2015-02-10

Review 2.  Exhaled nitric oxide: a new lung function test.

Authors:  P J Barnes; S A Kharitonov
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

3.  Selective inhibition of human inducible nitric oxide synthase by S-alkyl-L-isothiocitrulline-containing dipeptides.

Authors:  J M Park; T Higuchi; K Kikuchi; Y Urano; H Hori; T Nishino; J Aoki; K Inoue; T Nagano
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

4.  Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo.

Authors:  J i Oyama; H Shimokawa; H Momii; X Cheng; N Fukuyama; Y Arai; K Egashira; H Nakazawa; A Takeshita
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; G M Campo; M Ioculano; P Canale; F Rossi; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 6.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats.

Authors:  J Conger; J Robinette; A Villar; L Raij; P Shultz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.

Authors:  C C Wu; S J Chen; C Szabó; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies.

Authors:  P G Jorens; J R Boelaert; V Halloy; R Zamora; Y J Schneider; A G Herman
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.

Authors:  G J Southan; B Zingarelli; M O'Connor; A L Salzman; C Szabó
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.